In these cancers, statistical studies and meta-analyses have revealed that the overexpression of ANRIL was positively correlated with advanced TNM stage and occurrence of lymph node metastases, and constituted an independent predictor of adverse overall survival [16]. The gene discussed is CDKN2B-AS1; the disease is cancer.